当前位置:首页 - 行情中心 - 普利制药(300630) - 财务分析

普利制药

(300630)

  

流通市值:49.09亿  总市值:65.55亿
流通股本:3.38亿   总股本:4.52亿

普利制药(300630)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润4.04亿元,每股收益0.93元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益314239.34万元,未分配利润183409.53万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产668731.62万元,负债354492.27万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入1,352,234,193.69834,040,351.84373,166,292.21,806,344,586.37
营业总成本968,931,149.46585,355,540.06243,515,781.31,382,121,378.45
营业利润410,989,889.33278,018,301.06139,489,924.37439,501,880.08
利润总额410,937,602.33278,105,221.95139,509,242.11438,916,511.65
净利润404,300,300.32269,945,559.95138,433,086.41420,615,707.64
其他综合收益----
综合收益总额404,300,300.32269,945,559.95138,433,086.41420,615,707.64
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计2,722,403,963.22,353,730,362.972,410,563,725.642,443,097,518.1
非流动资产合计3,964,912,199.913,945,950,234.253,788,464,302.963,515,923,309.87
资产总计6,687,316,163.116,299,680,597.226,199,028,028.65,959,020,827.97
流动负债合计1,411,094,485.27938,447,129.21,248,308,071.791,484,098,044.1
非流动负债合计2,133,828,250.82,348,104,431.422,010,225,404.921,672,412,152.73
负债合计3,544,922,736.073,286,551,560.623,258,533,476.713,156,510,196.83
归属于母公司股东权益合计3,142,393,427.043,013,129,036.62,940,494,551.892,802,510,631.14
股东权益合计3,142,393,427.043,013,129,036.62,940,494,551.892,802,510,631.14
负债和股东权益合计6,687,316,163.116,299,680,597.226,199,028,028.65,959,020,827.97
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计1,244,658,815.12900,089,112.48446,383,829.961,860,253,263.79
经营活动现金流出小计1,214,163,753.52826,487,177.96417,600,964.251,325,958,454.5
经营活动产生的现金流量净额30,495,061.673,601,934.5228,782,865.71534,294,809.29
投资活动现金流入小计---91,508,445.75
投资活动现金流出小计629,625,927.07600,081,284.9380,887,181.561,066,876,218.04
投资活动产生的现金流量净额-629,625,927.07-600,081,284.9-380,887,181.56-975,367,772.29
筹资活动现金流入小计970,011,770780,011,770416,411,7701,960,475,641.11
筹资活动现金流出小计774,315,076.45630,777,173.23279,174,943.971,217,604,089.6
筹资活动产生的现金流量净额195,696,693.55149,234,596.77137,236,826.03742,871,551.51
汇率变动对现金及现金等价物的影响2,239,187.152,328,489.0189,606.764,491,277.97
现金及现金等价物净增加额-401,194,984.77-374,916,264.6-214,777,883.06306,289,866.48
期末现金及现金等价物余额343,961,158.86370,239,879.03530,378,260.57745,156,143.63
TOP↑